Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies. | Curr Pharm Biotechnol;12(6): 923-30, 2011 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.

de Ruijter, J; Valstar, M J; Wijburg, F A.

Affiliation

de Ruijter J; Department of Pediatrics, Academic Medical Center, Amsterdam, The Netherlands.

Curr Pharm Biotechnol ; 12(6): 923-30, 2011 Jun.

Article in En | MEDLINE | ID: mdl-21235449

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Mucopolysaccharidosis III / Molecular Chaperones / Hematopoietic Stem Cell Transplantation / Enzyme Replacement Therapy Limits: Animals / Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genetic Therapy / Mucopolysaccharidosis III / Molecular Chaperones / Hematopoietic Stem Cell Transplantation / Enzyme Replacement Therapy Limits: Animals / Humans Language: En Journal: Curr Pharm Biotechnol Journal subject: BIOTECNOLOGIA / FARMACOLOGIA Year: 2011 Document type: Article Affiliation country: Country of publication: